Evidence map›Paper›PMID 30917010›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia.

Rafal Bartoszewski, Adrianna Moszyńska, Marcin Serocki, Aleksandra Cabaj, Andreas Polten, Renata Ochocka, Louis Dell'Italia, Sylwia Bartoszewska, Jarosław Króliczewski, Michał Dąbrowski and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 204 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Mechanisms underlying end-organ injury in sleep apnoea.The European respiratory journal · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. International journal of chronic obstructive pulmonary disease · 2026
    Article
  18. Article
  19. Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Rafal BartoszewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Adrianna MoszyńskaDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Marcin SerockiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Aleksandra CabajLaboratory of Bioinformatics, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
Andreas PoltenAgilent Technologies Sales and Services, Waldbronn, Germany.
Renata OchockaDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Louis Dell'ItaliaDepartment of Medicine, Birmingham Veterans Affairs (VA) Medical Center, Birmingham, Alabama, USA.
Sylwia BartoszewskaDepartment of Inorganic Chemistry, Medical University of Gdansk, Gdansk, Poland.
Jarosław KróliczewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Michał DąbrowskiLaboratory of Bioinformatics, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
James F CollawnDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Gdańsk Medical University · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLAgilent Technologies (United States) · USBirmingham VA Medical Center · USUniversity of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
NIDDK NIH HHS P30 DK072482NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

During hypoxia, a cellular adaptive response activates hypoxia-inducible factors (HIFs; HIF-1 and HIF-2) that respond to low tissue-oxygen levels and induce the expression of a number of genes that promote angiogenesis, energy metabolism, and cell survival. HIF-1 and HIF-2 regulate endothelial cell (EC) adaptation by activating gene-signaling cascades that promote endothelial migration, growth, and differentiation. An HIF-1 to HIF-2 transition or switch governs this process from acute to prolonged hypoxia. In the present study, we evaluated the mechanisms governing the HIF switch in 10 different primary human ECs from different vascular beds during the early stages of hypoxia. The studies demonstrate that the switch from HIF-1 to HIF-2 constitutes a universal mechanism of cellular adaptation to hypoxic stress and that

Indexed as

Adaptation, PhysiologicalAortaBasic Helix-Loop-Helix ProteinsCell HypoxiaCells, CulturedEndothelial CellsEndothelial PAS Domain-Containing Protein 1FemaleGene Expression ProfilingGene Expression RegulationHalf-LifeHumansHuman Umbilical Vein Endothelial CellsHypoxia-Inducible Factor 1, alpha SubunitIliac ArteryOrgan SpecificityBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitRNA, Messengerhuman endothelial cells

Identifiers

PMID30917010
PMCPMC6593883
OpenAlexW2923377894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.